Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S.W. Borgers, Marit M. van Buuren, Brian J. McCarthy et al.|Nature Medicine|2025Cited by 40
Circulating CD8 <sup>+</sup> mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patientsVictoria M. Vorwald, Richard P. Tobin, Dana M. Davis et al.|Clinical & Translational Immunology|2022Cited by 26
Circulating CD8+ MAIT cells correlate with improved outcomes in anti-PD1 treated melanoma patientsVictoria M. Vorwald, Richard P. Tobin, Dana M. Davis et al.|medRxiv|2020Cited by 1